Takeda Pharmaceutical Company

Youtube Subscribe

Open: 15.34 Close: 15.35 Change: 0.01

The 15 top things that an AI found about Takeda Pharmaceutical Company and you do not know…

The game is changing. There is a new strategy to evaluate Takeda Pharmaceutical Company fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Takeda Pharmaceutical Company are: Takeda, Pharmaceutical, Company, Limited, company, …

Concept Map

Semantic Network

Stock Summary

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, onc.

Today's Summary

Takeda Pharmaceutical Company Limited has a fifty-two week low of $12.28 and a 50-two-week high of $17.15. Ballentine Partners LLC acquired shares in Takedi Pharmaceutical Company. Analysts predict an estimated EPS of 0.37 for the current fiscal year.

Today's News

Takeda Pharmaceutical Company Limited has a fifty-two week low of $12.28 and a 50-two-week high of $17.15. As a group, equities research analysts predict that the company will post 0.32 earnings per share for the current year. Takeda Pharmaceutical Company Limited is one of the largest pharmaceutical companies in the world. The company has a long history of innovation and excellence in the pharmaceutical industry. It is known for its innovative and high-quality drugs. Ballentine Partners LLC acquired shares in Takeda Pharmaceutical Company Limited. Analysts predict an estimated EPS of 0.37 for the current fiscal year. The alliance ushers in an unprecedented era of possibilities within both organizations.

Stock Profile

"Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., ZEDIRA GmbH, and Dr. Falk Pharma GmbH, as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan."

Keywords

Are looking for the most relevant information about Takeda Pharmaceutical Company? Investor spend a lot of time searching for information to make investment decisions in Takeda Pharmaceutical Company. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Takeda Pharmaceutical Company are: Takeda, Pharmaceutical, Company, Limited, company, predict, share, and the most common words in the summary are: takeda, pharmaceutical, company, job, news, inc, new, . One of the sentences in the summary was: Analysts predict an estimated EPS of 0.37 for the current fiscal year.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #takeda #pharmaceutical #company #job #news #inc #new.

Read more →

Youtube Subscribe

---